Presentation is loading. Please wait.

Presentation is loading. Please wait.

Supplementary Figure S4

Published bySylvia Sasbrink Modified over 5 years ago

Similar presentations

Presentation on theme: "Supplementary Figure S4"— Presentation transcript:

1 Supplementary Figure S4
B siRNA control + etoposide siRNA ANK1 + etoposide 5.0 4.5 siRNA control 4.0 2.5 * 3.5 siRNA ANK1 2 * 3.0 Cell Index 2.5 siRNA control + etoposide 1.5 2.0 Cell Index * 1.5 siRNA ANK1 + etoposide 1 1.0 0.5 0.5 0.0 -0.5 5 10 15 20 25 30 35 40 45 50 24 36 42 Time (h) Time (h) C Migration at 24h siRNA control siRNA ANK1 siRNA control + etoposide siRNA ANK1 + etoposide D siRNA control + etop. siRNA ANK1 + etop. siRNA ANK1 siRNA control ANK-1 116 kDa PARP 89 kDa p-p53 (Ser15) γ-H2AX β-actin

Download ppt "Supplementary Figure S4"

Similar presentations

Supplementary Figure 1. Caspase 8 expression and activation and Fas expression in NSCLC and normal lung cell lines. A Western blot analysis of DR4 and.

Supplementary Figure 1. Caspase 8 expression and activation and Fas expression in NSCLC and normal lung cell lines. A Western blot analysis of DR4 and.
00.111000.1110 A375A375R2 Vemurafenib (µM) BRAF (Full Length) p61-BRAF Isoform pMEK pERK Tubulin Supplementary Figure S1 0.004.01.040.01.030.10.313100.01.11.

A375A375R2 Vemurafenib (µM) BRAF (Full Length) p61-BRAF Isoform pMEK pERK Tubulin Supplementary Figure S
Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE1965.810.7 WI380.131.9 MCF10A16.751.9 HCT116115.3177.6 HCT116.

Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE WI MCF10A HCT HCT116.
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
LKB1  -actin EGFR PARP1 Cyto Nuc Chro.ppt Cell fractionation b a c 6 h +Cherry-tTA-ER +GFP-KU70/80 or -LKB1 +I-Sce Ⅰ > 200 copies of TRE/I-SceI +Tamoxifen.

LKB1  -actin EGFR PARP1 Cyto Nuc Chro.ppt Cell fractionation b a c 6 h +Cherry-tTA-ER +GFP-KU70/80 or -LKB1 +I-Sce Ⅰ > 200 copies of TRE/I-SceI +Tamoxifen.
Adipose PancreasAorta MuscleHeart Liver LungKidney Testis Spleen Brian 18S p55 γ p55 α Figure S1 Tissue distribution of p55 . (A) Representative RT-PCR.

Adipose PancreasAorta MuscleHeart Liver LungKidney Testis Spleen Brian 18S p55 γ p55 α Figure S1 Tissue distribution of p55 . (A) Representative RT-PCR.
D Day 2Day 1Day 4Day 6 Day 1 Day 2 Day 4 Day 6 Biopsy Injury D0 D1 D2 D3 D4 D5 D6 Wound monitoring by endoscope & Intrarectal adminstration of LGG or HBSS.

D Day 2Day 1Day 4Day 6 Day 1 Day 2 Day 4 Day 6 Biopsy Injury D0 D1 D2 D3 D4 D5 D6 Wound monitoring by endoscope & Intrarectal adminstration of LGG or HBSS.
Figure 1 B D DOX ( μ M) C Cell Proliferation (% Con) MCF-7MCF-7/DOX 0 0.1 1 DOX ( μ M) 0.03% 38.79% 0.15% 0.10% 0.20% 0.05% 0 20 40 60 80 100 120 00.110.

Figure 1 B D DOX ( μ M) C Cell Proliferation (% Con) MCF-7MCF-7/DOX DOX ( μ M) 0.03% 38.79% 0.15% 0.10% 0.20% 0.05%
Supplemental Figure S1 ResidueMass Delta Mass Sequence Mascot Ion Score 62 - 701064.640.04R.DFGLLVFVR.K49 125 - 133994.680.04K.IPALDLLIK.L56 156 - 163939.550.04K.FYGELALK.K34.

Supplemental Figure S1 ResidueMass Delta Mass Sequence Mascot Ion Score R.DFGLLVFVR.K K.IPALDLLIK.L K.FYGELALK.K34.
Farmer et al Supplementary Figure 1 KU0058684 PARP-1 IC 50 = 3.2nM KU0058948 PARP-1 IC 50 = 3.4nM KU0051529 PARP-1 IC 50 = 730nM a b 0 0.001 0.01 0.1 1.

Farmer et al Supplementary Figure 1 KU PARP-1 IC 50 = 3.2nM KU PARP-1 IC 50 = 3.4nM KU PARP-1 IC 50 = 730nM a b
0 10 20 30 40 50 60 70 80 90 100 013 5 SA-β-Gal positivity (%) Days after 6 Gy of IR exposure 3 Morphology SA-  -Gal 015 Supplementary Fig. S1 A B.

SA-β-Gal positivity (%) Days after 6 Gy of IR exposure 3 Morphology SA-  -Gal 015 Supplementary Fig. S1 A B.
Figure1 HER2 SKBr3 PC3 A. SKBr3 cells Figure1 0 0.03 0.3 3 30 (µM) 120 100 80 60 40 20 0 Penetratin control % of control 0 0.03 0.3 3 30 (µM) 120 100.

Figure1 HER2 SKBr3 PC3 A. SKBr3 cells Figure (µM) Penetratin control % of control (µM)
Supplementary figure 1A matrigel cell medium cells growing as spheroids in 3D cultures.

Supplementary figure 1A matrigel cell medium cells growing as spheroids in 3D cultures.
Supplementary information Figure S1 Parental Mock ANXA1-V5 GAPDH MCF7-EV MCF7-V5 4 5 ANXA1 ANXA1-V5 Tubulin MCF7-parental MCF7-EV MCF7-V5 1 2 3 A B C ANXA1.

Supplementary information Figure S1 Parental Mock ANXA1-V5 GAPDH MCF7-EV MCF7-V5 4 5 ANXA1 ANXA1-V5 Tubulin MCF7-parental MCF7-EV MCF7-V A B C ANXA1.
Supplementary Figure S1 a

Supplementary Figure S1 a
Supplementary Figure 1. A B C MP-MRT-AN KP-MRT-NS KP-MRT-RY KP-MRT-YM

Supplementary Figure 1. A B C MP-MRT-AN KP-MRT-NS KP-MRT-RY KP-MRT-YM
Supplementary data Figure S1 PBMC 20ug PBMC 5ug PBMC 1.25ug PBMC 0.3ug

Supplementary data Figure S1 PBMC 20ug PBMC 5ug PBMC 1.25ug PBMC 0.3ug
Progesterone receptor

Progesterone receptor
Neal et al.Supplementary Figure S1

Neal et al.Supplementary Figure S1
Supplemental Digital Content 4

Supplemental Digital Content 4

Similar presentations

Ads by Google